Hopp til hovedinnhold
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
NB
FR
EN
PT
NL
NB
DE
IT
Hjem
Company Press Releases
Company press releases
Abonner
Filtre
Filtre
Oppdater
Nullstill
Icon After
Dato
Toggle Visibility
Alle
I dag
Denne uken
Denne måneden
Tilpasset datosøk
Fra
Til
Kategori
Toggle Visibility
Alliances and agreements
Annen informasjonspliktig regulatorisk informasjon
Change in Capital
Commercial operations
Commercial results
Corporate life
Dividend
Eks.dato
Endringer i rettighetene til aksjer / verdipapirer
Flagging
General meeting / Board Meeting
Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll
Ikke-informasjonspliktige pressemeldinger
Income
Innsideinformasjon
Joint venture
Journal / appointments
Kapital- og stemmerettsendringer
Legal
Meetings / events
Meldepliktig handel for primærinnsidere
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Other financial transaction
Other subject
Polls / Surveys
Products and services
Prospekt / opptaksdokument
Rapportering om betaling til myndigheter (land-for-land rapportering)
Rating
Renteregulering
Sales
Share history
Share introduction and issues
Takeover bids
Trends / Analyses
Utsteders meldeplikt ved handel i egne aksjer
Valg av hjemstat
Årsrapporter og revisjonsberetninger
Leverandør
Toggle Visibility
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Viser 51 - 100 av 114 resultater
Tid
Selskap
Tittel
Sektor
Kategori
06 Sep 2023
07:30 CEST
THERAVET
TheraVet Reports Its 2023 Half-year Results and Provides an Update on the Development of Its Activities
20103015 Pharmaceuticals
Sales
06 Sep 2023
07:30 CEST
THERAVET
TheraVet publie ses résultats financiers du 1er semestre 2023 et fait le point sur le développement de ses activités
20103015 Pharmaceuticals
Sales
11 Jul 2023
07:30 CEST
THERAVET
TheraVet provides an update on its 2023 half-year development and portfolio strategy
20103015 Pharmaceuticals
New
11 Jul 2023
07:30 CEST
THERAVET
TheraVet fait le point sur son développement et sa stratégie de portefeuille au premier semestre 2023
20103015 Pharmaceuticals
New
15 Jun 2023
07:30 CEST
THERAVET
TheraVet Announces 300% Increase in Participating Centers in the Osteosarcoma Program Since Its Initiation 6 Months Ago
20103015 Pharmaceuticals
Other subject
15 Jun 2023
07:30 CEST
THERAVET
TheraVet annonce une augmentation de 300 % du nombre de centres participant au programme dédié à l’ostéosarcome depuis son lancement il y a six mois
20103015 Pharmaceuticals
Other subject
31 May 2023
07:30 CEST
THERAVET
TheraVet annonce le lancement commercial d'un substitut osseux à libération locale et prolongée d'antibiotiques
20103015 Pharmaceuticals
Products and services
31 May 2023
07:30 CEST
THERAVET
TheraVet Announces the Commercial Launch of a Local and Sustained Antibiotic Releasing Bone Substitute
20103015 Pharmaceuticals
Products and services
04 May 2023
07:30 CEST
THERAVET
TheraVet Continues the Assessment of BIOCERA-VET in a New Clinical Program
20103015 Pharmaceuticals
Other subject
04 May 2023
07:30 CEST
THERAVET
TheraVet poursuit l'évaluation de BIOCERA-VET dans un nouveau programme clinique
20103015 Pharmaceuticals
Other subject
25 Apr 2023
07:30 CEST
THERAVET
TheraVet publie ses résultats annuels pour l’exercice 2022 et met à disposition les documents préparatoires pour l’Assemblée Générale du 1er juin 2023
20103015 Pharmaceuticals
Sales
25 Apr 2023
07:30 CEST
THERAVET
TheraVet reports Full-Year 2022 Financial Results and provides the preparatory documents for the General Assembly of June 1st, 2023
20103015 Pharmaceuticals
Sales
06 Apr 2023
07:30 CEST
THERAVET
TheraVet Launches its Osteosarcoma Reference Centers Program
20103015 Pharmaceuticals
Other subject
06 Apr 2023
07:30 CEST
THERAVET
TheraVet annonce le lancement de son programme de Centres de Référence dédié à l'Ostéosarcome
20103015 Pharmaceuticals
Other subject
28 Mar 2023
07:30 CEST
THERAVET
TheraVet Updates on Its Development and Portfolio Strategy
20103015 Pharmaceuticals
Other subject
28 Mar 2023
07:30 CEST
THERAVET
TheraVet fait le point sur sa stratégie de développement et de portefeuille produits
20103015 Pharmaceuticals
Other subject
21 Feb 2023
07:30 CET
THERAVET
TheraVet Signs an International Distribution Agreement for BIOCERA-VET® Covering 24 Countries
20103015 Pharmaceuticals
News contracts
21 Feb 2023
07:30 CET
THERAVET
TheraVet signe un accord de distribution à l’international pour BIOCERA-VET® couvrant 24 pays
20103015 Pharmaceuticals
News contracts
15 Feb 2023
17:45 CET
THERAVET
TheraVet Announces the Start of the Assessment of BIOCERA-VET® in Horse Bone Cyst
20103015 Pharmaceuticals
Other subject
15 Feb 2023
17:45 CET
THERAVET
TheraVet annonce le début de l'évaluation de BIOCERA-VET® dans le traitement du kyste osseux chez le cheval
20103015 Pharmaceuticals
Other subject
12 Dec 2022
07:30 CET
THERAVET
TheraVet Optimizes Its Commercial Strategy in France With a New Distribution Agreement for Its BIOCERA-VET® Range
20103015 Pharmaceuticals
News contracts
12 Dec 2022
07:30 CET
THERAVET
TheraVet optimise sa stratégie commerciale en France avec un nouvel accord de distribution pour sa gamme BIOCERA-VET®
20103015 Pharmaceuticals
News contracts
07 Dec 2022
07:30 CET
THERAVET
TheraVet : BIOCERA-VET® nominé au Prix de l’Innovation Vétérinaire (AFVAC 2022)
20103015 Pharmaceuticals
Other subject
07 Dec 2022
07:30 CET
THERAVET
TheraVet: BIOCERA-VET® Nominated for the Veterinary Innovation Award (AFVAC 2022)
20103015 Pharmaceuticals
Other subject
26 Sep 2022
07:30 CEST
THERAVET
TheraVet annonce un accord de distribution exclusif pour BIOCERA-VET® aux États-Unis
20103015 Pharmaceuticals
News contracts
26 Sep 2022
07:30 CEST
THERAVET
TheraVet Announces an Exclusive Distribution Agreement for BIOCERA-VET® in the USA
20103015 Pharmaceuticals
News contracts
19 Sep 2022
07:30 CEST
THERAVET
TheraVet annonce sa participation au congrès de l’ESVOT 2022 avec 3 communications scientifiques
20103015 Pharmaceuticals
Meetings / events
19 Sep 2022
07:30 CEST
THERAVET
TheraVet Announces Its Participation in the 2022 ESVOT Congress With 3 Scientific Communications
20103015 Pharmaceuticals
Meetings / events
09 Sep 2022
07:30 CEST
THERAVET
TheraVet Reports Its 2022 Half-year Results and Provides an Update on the Development of Its Activities
20103015 Pharmaceuticals
Other subject
09 Sep 2022
07:30 CEST
THERAVET
TheraVet publie ses résultats financiers du 1er semestre 2022 et fait le point sur le développement de ses activités
20103015 Pharmaceuticals
Other subject
30 Jun 2022
17:45 CEST
THERAVET
TheraVet Provides Its 2022 First Half-year Operational Update
20103015 Pharmaceuticals
Other subject
30 Jun 2022
17:45 CEST
THERAVET
TheraVet publie son point d’activité du 1er semestre 2022
20103015 Pharmaceuticals
Other subject
30 Jun 2022
07:30 CEST
THERAVET
TheraVet Annonces the Commercial Launch of its BIOCERA-VET Product Line in the United States of America
20103015 Pharmaceuticals
Other subject
30 Jun 2022
07:30 CEST
THERAVET
TheraVet annonce le lancement commercial de sa gamme de produits BIOCERA-VET® aux États-Unis
20103015 Pharmaceuticals
Other subject
02 Jun 2022
07:30 CEST
THERAVET
TheraVet Annonces the Commercial Launch of the Most Comprehensive Line of Bone Substitutes in the Veterinary Market
20103015 Pharmaceuticals
Other subject
02 Jun 2022
07:30 CEST
THERAVET
TheraVet annonce le lancement de la gamme de substituts osseux la plus complète pour le marché vétérinaire
20103015 Pharmaceuticals
Other subject
30 May 2022
07:30 CEST
THERAVET
TheraVet Signs a Distribution Agreement With Nuzoa, a Leading Spanish Company in the Distribution of Veterinary Products and Services
20103015 Pharmaceuticals
Other subject
30 May 2022
07:30 CEST
THERAVET
TheraVet signe un accord de distribution avec Nuzoa, une société espagnole leader dans la distribution de produits et services vétérinaires
20103015 Pharmaceuticals
Other subject
12 May 2022
07:30 CEST
THERAVET
TheraVet: General Meeting of June 2, 2022: Availability of Preparatory Documents
20103015 Pharmaceuticals
Other subject
12 May 2022
07:30 CEST
THERAVET
TheraVet : Assemblée générale du 2 juin 2022 : mise à disposition des documents préparatoires
20103015 Pharmaceuticals
Other subject
10 May 2022
07:30 CEST
THERAVET
TheraVet signe un important accord de distribution avec le distributeur d’instruments orthopédiques et chirurgicaux Veterinary Instrumentation
20103015 Pharmaceuticals
Other subject
10 May 2022
07:30 CEST
THERAVET
TheraVet Signs an Important Distribution Agreement With the Orthopaedics & Surgical Instrumentation Distributor, Veterinary Instrumentation
20103015 Pharmaceuticals
Other subject
06 Apr 2022
07:30 CEST
THERAVET
TheraVet publie ses résultats annuels de l’exercice 2021 et confirme ses perspectives ambitieuses de développement et de commercialisation pour 2022
20103015 Pharmaceuticals
Other subject
06 Apr 2022
07:30 CEST
THERAVET
TheraVet Reports Full Year 2021 Financial Results and Confirms Its Ambitious Development and Commercial Plans for 2022
20103015 Pharmaceuticals
Other subject
28 Mar 2022
07:30 CEST
THERAVET
TheraVet: Market-making Agreement with Banque Rothschild
20103015 Pharmaceuticals
Other subject
28 Mar 2022
07:30 CEST
THERAVET
TheraVet : Mise en œuvre d’un contrat d’animation de marché avec la banque Rothschild
20103015 Pharmaceuticals
Other subject
15 Mar 2022
07:30 CET
THERAVET
TheraVet: Commercial Launch of BIOCERA-VET® in United Kingdom and Ireland
20103015 Pharmaceuticals
Other subject
15 Mar 2022
07:30 CET
THERAVET
TheraVet : Lancement commercial de BIOCERA-VET® au Royaume-Uni et en Irlande
20103015 Pharmaceuticals
Other subject
07 Feb 2022
07:30 CET
THERAVET
TheraVet élargit son portefeuille de substituts osseux avec une gamme innovante de greffons biologiques
20103015 Pharmaceuticals
Other subject
07 Feb 2022
07:30 CET
THERAVET
TheraVet Broadens Its Bone Substitutes Portfolio With an Innovative Line of Biological Bone Grafts
20103015 Pharmaceuticals
Other subject
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Sider
«
« First
‹
‹‹
1
2
3
›
››
»
Last »
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
Hjem
Markeder
Amsterdam
Cash Products
Aksjer
AEX index Stocks
AEX ESG Stocks
Indekser
Fond
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksopsjoner
Indeksfutures
Aksjeopsjoner
Utbyttederivater
Aksjefutures
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Brussel
Cash products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Expert Market
Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Lisboa
Cash Products
Aksjer
Euronext regulated
Euronext Access
PSI Stocks
Indekser
Obligasjoner
Derivater
Indeksfutures
Stock options
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Milan
Cash Products
Stocks
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Euronext Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Stocks
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Funds
Derivative products
All derivatives
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
IPOs
Oslo
Aksjer, renter, indekser
Aksjer
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX aksjer
OBX ESG aksjer
OSEBX aksjer
OSEFX Aksjer
Seafood Aksjer
Shipping Aksjer
Aksjeindekser
Obligasjoner
Oslo Børs
Nordic Alternative Bond Market
Obligasjonsindekser
ETFer
Fond
Derivater
Derivative products
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Finanskalender
Primærinnsidere
Paris
Cash Products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Aksjer
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Euronext Global Equity Market
EuroTLX
Trading After Hours
Selskapsmeldinger
Latest
Archive
Nye aksjenoteringer
Alle aksjenoteringer
Euronext Growth advisors
Euronext Tech Leaders
Family business
Indekser
Directory
Grønne indekser
Indices documents
Indices news
Indekser høringer
Kontakter Euronext-indekser
ETF-er
Directory
Grønne ETF-er
Fond
Directory
ESG Funds
Oslo Mutual Funds
Obligasjoner
Grønne obligasjoner
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Strukturerte produkter
Directory / search
Bid-Only trading status
Trading Turbos in the Netherlands
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
ETF opsjoner
Kontraktsspesifikasjoner
Tick sizes
Rapportering av handler
Leverandørkoder markedsdata
Råvarer
Quotes
Quotes snapshot
Milling Wheat futures
Rapeseed futures
Corn futures
European Durum Wheat Futures
Milling Wheat options
Rapeseed options
Corn options
Bortfallskalendre
Bortfall
Wholesale Trading
Commitments of Traders (CoT) report
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Knowledge Centre
Bid & Ask
Options Investing E-learning
Contract Specifications
Position Management
Intrinsic Value
Premium & Valuation
Moneyness
Positions
Euronext News
Ressurser
Statistikk & rapporter
Quality of execution
Åpningstider
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Markedshendelser
Suspenderte instrumenter
Stressed Market Conditions
Brudd på Double Cap limits
Ekstraordinære markedsforhold
Diverse meldinger
Market status
Medlemsliste
Issuers compliance
Hvor du finner hva